LivaNova completes feasibility study of Caisson TMVR system
UK-based medical technology company LivaNova has completed the PRELUDE feasibility study of its transcatheter mitral valve replacement (TMVR) system called…
UK-based medical technology company LivaNova has completed the PRELUDE feasibility study of its transcatheter mitral valve replacement (TMVR) system called…
Abbott has launched a clinical trial of its investigational Tendyne Transcatheter Mitral Valve Replacement (TMVR) device in the US to…